vs
Side-by-side financial comparison of Borr Drilling Ltd (BORR) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($397.6M vs $267.7M, roughly 1.5× Borr Drilling Ltd). Borr Drilling Ltd runs the higher net margin — 13.1% vs 5.3%, a 7.8% gap on every dollar of revenue.
Borr Drilling Ltd is a global offshore drilling contractor owning and operating a modern fleet of high-spec jack-up rigs. It offers drilling services to oil and gas exploration and production firms, with main operations across the North Sea, Southeast Asia, Middle East, and West Africa for shallow-water and marginal field projects.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
BORR vs GRDN — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $267.7M | $397.6M |
| Net Profit | $35.1M | $20.9M |
| Gross Margin | — | 21.5% |
| Operating Margin | 36.0% | 7.7% |
| Net Margin | 13.1% | 5.3% |
| Revenue YoY | -1.5% | — |
| Net Profit YoY | 10.7% | — |
| EPS (diluted) | $0.14 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $397.6M | ||
| Q3 25 | — | $377.4M | ||
| Q2 25 | $267.7M | $344.3M | ||
| Q1 25 | — | $329.3M | ||
| Q3 24 | — | $314.4M | ||
| Q2 24 | $271.9M | — | ||
| Q2 23 | $187.5M | — | ||
| Q2 22 | $105.3M | — |
| Q4 25 | — | $20.9M | ||
| Q3 25 | — | $9.8M | ||
| Q2 25 | $35.1M | $9.0M | ||
| Q1 25 | — | $9.4M | ||
| Q3 24 | — | $-122.0M | ||
| Q2 24 | $31.7M | — | ||
| Q2 23 | $800.0K | — | ||
| Q2 22 | $-165.3M | — |
| Q4 25 | — | 21.5% | ||
| Q3 25 | — | 19.8% | ||
| Q2 25 | — | 19.8% | ||
| Q1 25 | — | 19.5% | ||
| Q3 24 | — | 19.4% | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q4 25 | — | 7.7% | ||
| Q3 25 | — | 4.3% | ||
| Q2 25 | 36.0% | 3.7% | ||
| Q1 25 | — | 3.9% | ||
| Q3 24 | — | -33.3% | ||
| Q2 24 | 38.4% | — | ||
| Q2 23 | 31.9% | — | ||
| Q2 22 | -116.8% | — |
| Q4 25 | — | 5.3% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | 13.1% | 2.6% | ||
| Q1 25 | — | 2.9% | ||
| Q3 24 | — | -38.8% | ||
| Q2 24 | 11.7% | — | ||
| Q2 23 | 0.4% | — | ||
| Q2 22 | -157.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $0.14 | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $0.12 | — | ||
| Q2 23 | $0.00 | — | ||
| Q2 22 | $-1.09 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $92.4M | $65.6M |
| Total DebtLower is stronger | — | $0 |
| Stockholders' EquityBook value | $1.0B | $217.9M |
| Total Assets | $3.4B | $412.7M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $65.6M | ||
| Q3 25 | — | $36.5M | ||
| Q2 25 | $92.4M | $18.8M | ||
| Q1 25 | — | $14.0M | ||
| Q3 24 | — | $37.2M | ||
| Q2 24 | $195.3M | — | ||
| Q2 23 | $83.8M | — | ||
| Q2 22 | $29.7M | — |
| Q4 25 | — | $0 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | $34.3M | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | $281.8M | — |
| Q4 25 | — | $217.9M | ||
| Q3 25 | — | $195.5M | ||
| Q2 25 | $1.0B | $179.7M | ||
| Q1 25 | — | $163.2M | ||
| Q3 24 | — | $133.9M | ||
| Q2 24 | $999.2M | — | ||
| Q2 23 | $906.2M | — | ||
| Q2 22 | $711.5M | — |
| Q4 25 | — | $412.7M | ||
| Q3 25 | — | $390.0M | ||
| Q2 25 | $3.4B | $356.3M | ||
| Q1 25 | — | $334.0M | ||
| Q3 24 | — | $348.0M | ||
| Q2 24 | $3.2B | — | ||
| Q2 23 | $3.0B | — | ||
| Q2 22 | $3.0B | — |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | 0.26× | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | 0.40× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.3M | $34.6M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 0.18× | 1.65× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $34.6M | ||
| Q3 25 | — | $28.2M | ||
| Q2 25 | $6.3M | $19.9M | ||
| Q1 25 | — | $17.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | $16.0M | — | ||
| Q2 23 | $2.4M | — | ||
| Q2 22 | $-8.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $24.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 6.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q4 25 | — | 1.65× | ||
| Q3 25 | — | 2.87× | ||
| Q2 25 | 0.18× | 2.21× | ||
| Q1 25 | — | 1.86× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.50× | — | ||
| Q2 23 | 3.00× | — | ||
| Q2 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BORR
| Transferred Over Time | $256.6M | 96% |
| Transferred At Point In Time | $11.1M | 4% |
GRDN
Segment breakdown not available.
